Skip to main content
Clinical Trials/NCT03364179
NCT03364179
Completed
Not Applicable

IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany (EPYLOGE-Study)

Technical University of Munich1 site in 1 country300 target enrollmentAugust 19, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Advanced Dementia Stages
Sponsor
Technical University of Munich
Enrollment
300
Locations
1
Primary Endpoint
patient´s comfort of dying with dementia
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

From a scientific view, palliative care issues in dementia are neglected in Germany. Neither in Germany nor internationally research has been conducted on palliative care issues in young onset dementia (YOD), although significant differences compared to late onset dementia (LOD) are expected. Most international studies have focused on patients in long term care (LTC) facilities but have neglected patients that are cared for at home. We hypothesize that in advanced and terminal stages of YOD and LOD unmet care needs exist and that they differ between YOD and LOD. By prospectively assessing and surveying 200 patients with YOD and LOD in advanced stages who are cared for in LTC facilities and at home and investigating circumstances of death of 100 YOD- and LOD-patients, it is possible 1) to describe symptoms and management, health care utilization, palliative care provision, quality of life and death, elements of advance care planning, family caregivers' needs and satisfaction; 2) to compare YOD and LOD; 3) to develop expert-consensus recommendations derived from study results for the improvement and implementation of strategies and interventions for palliative care provision. 4) to communicate the recommendations nationally and internationally in order to improve and adapt guidelines, to implement the recommendations into daily practice and to give a basis and perspectives for future research projects; to communicate the results to patients and their families in order to counsel and support them in their decision making processes and their dialogue with professional caregivers and physicians.

Registry
clinicaltrials.gov
Start Date
August 19, 2017
End Date
January 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Technical University of Munich
Responsible Party
Principal Investigator
Principal Investigator

Janine Diehl-Schmid

Clinical Professor, Principle Investigator

Technical University of Munich

Eligibility Criteria

Inclusion Criteria

  • Patient with moderate or severe dementia (CDR = 2 or 3)
  • Patient lives at home or in long term care
  • Patient has got a family caregiver \> 18 years
  • Family caregiver has sufficient knowledge of German language
  • Written informed consent of family caregiver
  • Written informed consent of patient or legal representative, respectively
  • Documents of legal representative/ Power of attorney
  • Exclusion criteria
  • at least one inclusion criterion is not met

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

patient´s comfort of dying with dementia

Time Frame: Assessment B at the latest 4 months after patient's death

Comfort assessment of dying with dementia (CAD-EOLD)-Scale: Subscale of End of Life in Dementia Scale (EOLD), 14 symptoms/ conditions during patient´s dying process to be rated by proxy, Score 1-3 each. Total sum score range 14 to 42. 42 means highest level of comfort during dying process.

patient´s quality of life in late stage dementia

Time Frame: Baseline

Quality of ife in late-stage dementia scale (QUALID-Scale): 11 questions, Score 1 to 5 each, total sum score range 11 to 55, 11 means highest quality of life

Secondary Outcomes

  • family caregivers' burden and coping(Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))
  • palliative care provision in late-stage dementia and during the dying process(Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))
  • symptoms and symptom management in late-stage dementia and during the dying process(Assessment A (study inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))
  • family caregivers´satisfaction with care(Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))
  • health care utilization in late-stage dementia and during the dying process(Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))
  • Caregivers' problems, challenges, barriers, needs, preferences in late-stage dementia and during the dying process(Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death))

Study Sites (1)

Loading locations...

Similar Trials